Consensus by Chinese Expert Panel on Chlamydia trachomatis-Resistant and Chlamydia trachomatis-Persistent Infection

二维码有效期 120s

摘要Chlamydia trachomatis (Ct) genital infection is the most common sexually transmitted disease (STD) in China and the US. The morbidity of Ct genital infection in China has increased from 32.48/100,000 in 2008 to 37.18/100,000 in 2015.[1] The major areas of Ct infections are concentrated in the Zhujiang Delta, Changjiang Delta, Minjiang Area, and West China. In these areas, the highest incidence of Ct infection reaches 615.99/100,000 citizens. In the US, there are 1,441,789 reported Ct, which include 627.2 females and 278.4 males per 100,000 population. It is now the most prevalent STD, with its rate increasing to 22% in males and 6% in females.[2] Ct genital infection can cause epididymitis, prostatitis, cervicitis, annexitis, infertility, and atopic pregnancy, which have been identified as the major public health problems.

作者单位 Department of Dermatovenerology, Tianjin Medical University General Hospital, Tianjin Neurological Institute, Ministry of Education and Tianjin City Key Laboratory of Post?neuroinjury Neuro?repair and Regeneration in Central Nervous System, Tianjin 300052, China ^[1] Department of Dermatovenerology, Tianjin Union Medical Center, Tianjin 300121, China ^[2] Department of Clinical Management, National Center of STD Control, Institute of Dermatology, Chinese Academy of Medical Sciences, China CDC, Nanjing, Jiangsu 210042, China ^[3] Department of Dermatovenerology, The First Affiliated Hospital, Sun Yat?sen University, Guangzhou, Guangdong 510080, China ^[4] Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College, Nanjing, Jiangsu 210042, China ^[5] Department of Dermatovenerology, Beijing Ditan Hospital Capital Medical University, Beijing 100015, China ^[6] Department of Dermatology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310020, China ^[7] Department of Dermatology, Huashan Hospital, Fudan University, Shanghai 200040, China ^[8] Shandong Provincial Institute of Dermatology and Venereology, Provincial Academy of Medical Science, Jinan, Shandong 250022, China ^[9] Department of Dermatovenerology, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, China ^[10] Department of Infection Management and Disease Prevention, China?Japan Friendship Hospital, Beijing 100029, China ^[11] Department of Dermatovenerology, The Second Hospital of Shanxi Medical University, Taiyuan, Shanxi 030001, China ^[12] STD Institute, Shanghai Skin Disease Hospital, Shanghai 200050, China ^[13] Department of Dermatology, The First Affiliated Hospital of PLA General Hospital, Beijing 100048, China ^[14] Department of Dermatology, The First Hospital of China Medical University, Shenyang, Liaoning 110001, China ^[15] Department of Dermatovenerology, Shanghai General Hospital, Shanghai 200080, China ^[16] Department of Dermatovenerology, The 4th People's Hospital of Qinghai Province, Xining, Qinghai 810014, China ^[17] Department of Dermatovenerology, Shenzhen Hospital Southern Medical University, Shenzhen, Guangdong 518000, China ^[18]

关键词 Chlamydia trachomatis Persistent Infection Therapy Resistant

栏目名称

Criteria and Guidance

DOI 10.4103/0366-6999.219159

发布时间 2017-12-26

基金项目

a grant from the Natural Science Foundation of China （31370211）

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交